Clinical surfactant preparations mediate SOD and catalase uptake by type II cells and lung tissue

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 270, Issue 4 14-4, 1996, Pages

  Nieves Cruz, Bedford ^a   Rivera, Arnold ^c   Cifuentes, Javier ^c   Pataki, Gyorgy ^c   Matalon, Sadis ^c   Carlo, Waldemar A ^c   Tanswell, A Keith ^c   Freeman, Bruce ^b  

^a Leonard Chabert Medical Center   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c NONE

Author keywords

alveolar distribution; antioxidant enzymes; minimum surface tension; superoxide dismutase

Indexed keywords

ANTIOXIDANT; CATALASE; LUNG SURFACTANT; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELLULAR DISTRIBUTION; ENZYME ACTIVITY; FEMALE; FETUS LUNG; LUNG ALVEOLUS EPITHELIUM; LUNG DYSPLASIA; LUNG PARENCHYMA; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTITUTION THERAPY;

EID: 0029871036     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.1996.270.4.l659     Document Type: Article

References (44)

1. Baker, R. R., L. Czopf, T. Jilling, B. A. Freeman, K. L. Kirk, and S. Matalon. Quantitation of alveolar distribution of liposome-entrapped antioxidant enzymes. Am. J. Physiol. 263 (Lung Cell. Mol. Physiol. 7): L585-L594, 1992.
2. Bancalari, E., and T. Gerhardt. Bronchopulmonary dysplasia. Pediatr. Clin. North Am. 33: 1-23, 1986.
3. Barnard, M. L., R. R. Baker, and S. Matalon. Mitigation of oxidant injury to lung microvasculature by intratracheal instillation of antioxidant enzymes. Am. J. Physiol. 265 (Lung Cell. Mol. Physiol. 9): L340-L345, 1993.
4. Barnard, M. L., and S. Matalon. Mechanisms of extracellular reactive oxygen species injury to the pulmonary microvasculature. J. Appl. Physiol. 72: 1724-1729, 1992.
5. Blanchard, P. W., T. M. Brown, and A. L. Coates. Pharmacotherapy in bronchopulmonary dysplasia. Clin. Perinatol. 14: 881-910, 1987.
6. Caniggia, I., I. Tseu, R. N. N. Han, B. T. Smith, K. Tanswell, and M. Post. Spatial and temporal differences in fibroblast behavior in fetal rat lung. Am. J. Physiol. 261 (Lung Cell. Mol. Physiol. 5): L424-L433, 1991.
7. Cross, C. E., T. T. Watanabe, G. K. Hasegawa, G. N. Goralnik, K. E. Roertgen, T. Kaizu, K. M. Reiser, A. B. Gorin, and J. A. Last. Biochemical assays in lung homogenates: artifacts caused by trapped blood after perfusion. Toxicol. Appl. Pharmacol. 48: 99-109, 1979.
8. Davis, J. M., W. N. Rosenfeld, H. Koo, and A. Gonenne. Pharmacologic interactions of exogenous lung surfactant and recombinant human Cu/Zn superoxide dismutase. Pediatr. Res. 35: 37-40, 1994.
9. Davis, J. M., W. N. Rosenfeld, R. J. Sanders, and A. Gonenne. Prophylactic effects of recombinant human superoxide dismutase in neonatal lung injury. J. Appl. Physiol. 74: 2234-2241, 1993.
10. Enhorning, G. Pulsating bubble technique for evaluating pulmonary surfactant. J. Appl. Physiol 43: 198-203, 1977.
11. Evans, H. E., W. Rosenfeld, R. Jhaveri, L. Concepcion, and I. Zabaleta. Oxidant-mediated lung disease in newborn infants. J. Free Radical Biol. Med. 2: 369-372, 1986.
12. 2-rich environment: the antioxidant enzymes in the developing rabbit lung. Pediatr. Res. 18: 240-244, 1984.
13. Freeman, B. A., and J. D. Crapo. Biology of disease. Free radical and tissue injury. Lab. Invest. 47: 412-426, 1982.
14. Freeman, B. A., and K. Tanswell. Biochemical and cellular aspects of pulmonary oxygen toxicity. Free Radical Biol. Med. 1: 133-164, 1985.
15. Freeman, B. A., J. P. Turrens, Z. Mirza, J. D. Crapo, and S. L. Young. Modulation of oxidant lung injury by using liposomeentrapped superoxide dismutase and catalase. Federation Proc. 44: 2591-2595, 1985.
16. Fridovich, I., and B. A. Freeman. Antioxidant defenses of the lung. Annu. Rev. Physiol. 48: 693-702, 1986.
17. Gutierrez, H. H., B. R. Pitt, M. Schwarz, S. C. Watkins, C. Lowenstein, I. Caniggia, P. Chumley, and B. A. Freeman. Pulmonary alveolar epithelial inducible NO synthase gene expression: regulation by inflammatory mediators. Am. J. Physiol. 268 (Lung Cell. Mol. Physiol. 12): L501-L508, 1995.
18. Haddad, I. Y., H. Ischiropoulos, B. A. Holm, J. S. Beckman, J. R. Baker, and S. Matalon. Mechanisms of peroxynitrite-induced injury to pulmonary surfactants. Am. J. Physiol. 265 (Lung Cell. Mol. Physiol. 9): L555-L564, 1993.
19. Haddad, I. Y., B. A. Holm, L. Hlavaty, and S. Matalon. Dependence of surfactant function on extracellular pH: mechanisms and modifications. J. Appl. Physiol. 76: 657-662, 1994.
20. Haddad, I. Y., G. Pataki, P. Hu, C. Galliani, J. S. Beckman, and S. Matalon. Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury. J. Clin. Invest. 94: 2407-2413, 1994.
21. Hoekstra, R. E., J. C. Jackson, T. F. Myers, I. D. Frantz, M. E. Stern, W. F. Power, M. Maurer, J. R. Raye, S. T. Carrier, J. H. Gunkel, and A. J. Gold. Improved neonatal survival following multiple doses of bovine surfactant in very premature neonates at risk for respiratory distress syndrome. Pediatrics 88: 10-18, 1991.
22. Holm, B. A., R. H. Notter, J. Siegle, and S. Matalon. Pulmonary physiological and surfactant changes during injury and recovery from hyperoxia. J. Appl. Physiol. 59: 1402-1409, 1985.
23. Horbar, J. D., L. L. Wright, R. F. Soll, E. C. Wright, A. A. Faranoff, S. B. Korones, S. Shankaran, W. Oh, B. D. Fletcher, C. R. Bauer, J. E. Tyson, J. A. Lemons, E. F. Donovan, B. J. Stoll, D. D. Stevenson, L. Papile, and J. Phillips III. A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome. J. Pediatr. 123: 757-766, 1993.
24. Huie, R. E., and S. Padmaja. The reaction of NO with superoxide. Free Radical Res. Commun. 18: 195-199, 1993.
25. Jacobson, J. M., J. R. Michael, M. H. Jafri, and G. H. Gurtner. Antioxidants and antioxidant enzymes protect against pulmonary oxygen toxicity in the rabbit. J. Appl. Physiol. 68: 1252-1259, 1990.
26. Jurima-Romet, M., and P. N. Shek. Lung uptake of liposomeentrapped glutathione after intratracheal administration. J. Pharm. Pharmacol. 43: 6-10, 1991.
27. Labarca, C., and K. Paigen, A simple, rapid and sensitive DNA assay procedure. Anal. Biochem. 102: 344-352, 1980.
28. Luck, H. Methods in Enzymatic Analysis, edited by H. U. Bergmeyer. New York: Academic, 1963, p. 885-888.
29. Matalon, S., B. A. Holm, R. R. Baker, M. K. Whitfield, and B. A. Freeman. Characterization of antioxidant activities of pulmonary surfactant mixtures. Biochim. Biophys. Acta 1035: 121-127, 1990.
30. McCord, J. M., and I. Fridovich, Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J. Biol. Chem. 244: 6049-6055, 1969.
31. Merrit, T. A., M. Hallman, C. Berry, M. Pohjavuori, D. K. Edwards III, J. Jaaskelainen, M. R. Grafe, Y. Vaucher, P. Wozniak, G. Heldt, and J. Rapola. Randomized, placebo-controlled trial of human surfactant given at birth versus rescue administration in very low birth weight infants with lung immaturity. J. Pediatr. 118: 581-593, 1991.
32. Northway, W. H. Bronchopulmonary dysplasia: then and now. Arch. Dis. Child. 65: 1076-1081, 1990.
33. Northway, W. H., R. C. Rosan, and D. Y. Porter. Pulmonary disease following respirator therapy of hyaline membrane disease: bronchopulmonary dysplasia. N. Engl. J. Med. 276: 357-367, 1967.
34. Notter, R. H. Surface chemistry of pulmonary surfactant: the role of individual components. In: Pulmonary Surfactant, edited by B. Robertson, L. M. G. Van Golde, and J. J. Batenburg. Amsterdam: Elsevier, 1984, p. 17-65.
35. Shaffer, S. G., D. H. O'Neill, and D. W. Thibeault. Administration of bovine superoxide dismutase fails to prevent chronic pulmonary sequelae of neonatal oxygen exposure in the rat. J. Pediatr. 110: 942-946, 1987.
36. Tanswell, A. K., and B. A. Freeman. Pulmonary antioxidant enzyme maturation in fetal and neonatal rat. I. Developmental profiles. Pediatr. Res. 18: 584-587, 1984.
37. 2 toxicity in the newborn rat. J. Appl. Physiol. 63. 347-352, 1987.
38. The Osiris Collaborative Group. Early versus delayed neonatal administration of a synthetic surfactant-the judgment of OSIRIS. Lancet 340: 1363-1369, 1992.
39. Turrens, J. F., J. D. Crapo, and B. A. Freeman. Protection against oxygen toxicity by intravenous injection of liposomeentrapped catalase and superoxide dismutase J. Clin. Invest. 73: 87-95, 1984.
40. Walther, F. J., R. David-Cu, M. C. Supnet, M. L. Longo, B. R. Fan, and R. Bruni. Uptake of antioxidants in surfactant liposomes by cultured alveolar type II cells is enhanced by SP-A. Am. J. Physiol. 265 (Lung Cell. Mol. Physiol. 9): L330-L339, 1993.
41. Walther, F. J., C. E. M. Gidding, I. M. Kuipers, D. Willebrand, E. M. Bevers, A. Abuchowski, and A. T. Viau. Prevention of oxygen toxicity with superoxide dismutase and catalase in premature lambs. J. Free Radical Biol. Med. 2: 289-293, 1986.
42. Walther, F. J., F. L. Nunez, R. David-Cu, and K. E. Hill. Mitigation of pulmonary oxygen toxicity in rats by intratracheal instillation of polyethylene glycol-conjugated antioxidant enzymes. Pediatr. Res. 33: 332-335, 1993.
43. Watts, C. L., and A. A. Fanaroff, Fibronectin: role in respiratory distress syndrome and bronchopulmonary dysplasia. Semin. Perinatol. 16: 162-169, 1992.
44. White, C. W., J. H. Jackson, A. Abuchowski, G. M. Kazo, R. F. Mimmack, E. M. Berger, J. M. McCord, and J. E. Repine. Polyethylene glycol-attached antioxidant enzymes decrease pulmonary oxygen toxicity in rats. J. Appl. Physiol. 66: 584-590, 1989.